Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
Correlation between changes after 24 weeks treatment in body weight and creatinine eGFR ( A ), cystatin-C eGFR ( B ) and iohexol mGFR ( C )
You prefer a live video visit before starting treatment
Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: In vivo positron emission tomography and postmorten evidence
A clinician will evaluate your BMI, metabolic health, and recovery status to ensure treatment is safe and appropriate
Compare the PlexusDx approach: see the Weight Management Protocols, or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first
US$ 22.50
US$ 25.42
US$ 27.51
